Enterprise Value
113M
Cash
2.227M
Avg Qtr Burn
-4.905M
Short % of Float
7.83%
Insider Ownership
24.00%
Institutional Own.
10.62%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NurOwn (autologous MSC-NTF) Details Amyotrophic lateral sclerosis, Neurodegenerative disease Big Mover™ Suspected Mover™ Susp. Mover™ | PDUFA Adcomm | |
NurOwn (autologous MSC-NTF) Details Multiple sclerosis | Failed Discontinued |